The three-dimensional structure of caspase-8:: an initiator enzyme in apoptosis

被引:131
作者
Blanchard, H
Kodandapani, L
Mittl, PRE
Di Marco, S
Krebs, JF
Wu, JC
Tomaselli, KJ
Grütter, MG
机构
[1] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland
[2] IDUN Pharmaceut Inc, La Jolla, CA 92037 USA
[3] Novartis Pharma AG, Core Technol Area, CH-4002 Basel, Switzerland
[4] IRBM, I-00040 Rome, Italy
关键词
caspases; drug design; inhibitor binding; structure comparison; X-ray structure;
D O I
10.1016/S0969-2126(99)80179-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: In the initial stages of Fas-mediated apoptosis the cysteine protease caspase-8 is recruited to the cell receptor as a zymogen (procaspase-8) and is incorporated into the death-signalling complex. Procaspase-8 is subsequently activated leading to a cascade of proteolytic events, one of them being the activation of caspase-3, and ultimately resulting in cell destruction, Variations in the substrate specificity of different caspases have been reported. Results: We report here the crystal structure of a complex of the activated human caspase-8 (proteolytic domain) with the irreversible peptidic inhibitor Z-Glu-Val-Asp-dichloromethylketone at 2.8 Angstrom resolution. This is the first structure of a representative of the long prodomain initiator caspases and of the group III substrate specificity class. The overall protein architecture resembles the caspase-1 and caspase-3 folds, but shows distinct structural differences in regions forming the active site. In particular, differences observed in subsites S-3, S-4 and the loops involved in inhibitor interactions explain the preference of caspase-8 for substrates with the sequence (Leu/Val)-Glu-X-Asp, Conclusions: The structural differences could be correlated with the observed substrate specificities of caspase-1, caspase-3 and caspase-8, as determined from kinetic experiments. This information will help us to understand the role of the Various caspases in the propagation of the apoptotic signal. The information gained from this investigation should be useful for the design of specific inhibitors.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 41 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[3]   Neuroprotection by a caspase inhibitor in acute bacterial meningitis [J].
Braun, JS ;
Novak, R ;
Herzog, KH ;
Bodner, SM ;
Cleveland, JL ;
Tuomanen, EI .
NATURE MEDICINE, 1999, 5 (03) :298-302
[4]  
BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
[5]   Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 [J].
Chinnaiyan, AM ;
ORourke, K ;
Yu, GL ;
Lyons, RH ;
Garg, M ;
Duan, DR ;
Xing, L ;
Gentz, R ;
Ni, J ;
Dixit, VM .
SCIENCE, 1996, 274 (5289) :990-992
[6]   Prediction of the tertiary structure and substrate binding site of caspase-8 [J].
Chou, KC ;
Jones, D ;
Heinrikson, RL .
FEBS LETTERS, 1997, 419 (01) :49-54
[7]  
COWTAN K, 1994, JOINT CCP4 ESFEACBM, V32, P34
[8]  
Cryns Vincent L., 1998, P177
[9]   A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis [J].
Cursio, R ;
Gugenheim, J ;
Ricci, JE ;
Crenesse, D ;
Rostagno, P ;
Maulon, L ;
Saint-Paul, MC ;
Ferrua, B ;
Auberger, P .
FASEB JOURNAL, 1999, 13 (02) :253-261
[10]   Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cytotoxicity [J].
Ellerby, LM ;
Hackam, AS ;
Propp, SS ;
Ellerby, HM ;
Rabizadeh, S ;
Cashman, NR ;
Trifiro, MA ;
Pinsky, L ;
Wellington, CL ;
Salvesen, GS ;
Hayden, MR ;
Bredesen, DE .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :185-195